市場調査レポート
商品コード
1565617

ポイントオブケア診断:各種技術と世界市場

Point-of-Care Diagnostics: Technologies and Global Markets

出版日: | 発行: BCC Research | ページ情報: 英文 159 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=154.02円
ポイントオブケア診断:各種技術と世界市場
出版日: 2024年10月01日
発行: BCC Research
ページ情報: 英文 159 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のポイントオブケア診断の市場規模は、2023年の369億米ドル、2024年の406億米ドルから、予測期間中はCAGR 10.2%で推移し、2029年末には659億米ドルの規模に達すると予測されています。

北米市場は、2024年の168億米ドルから、10.5%のCAGRで推移し、2029年末には277億米ドルに成長すると予測されています。アジア太平洋地域は、2024年の91億米ドルから、11.2%のCAGRで推移し、2029年末には154億米ドルに成長すると予測されています。

当レポートでは、世界のポイントオブケア診断の市場を調査し、市場概要、市場影響因子および市場機会の分析、法規制環境、新興技術および技術開発の動向、市場規模の推移・予測、各種区分・地域別の詳細分析、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 概要
  • POCのための新しいアプローチ
  • 米国におけるCLIAの重要性
  • 規制ガイドライン
  • 適正製造規範
  • POC試験におけるFDAの役割
  • 総論

第3章 市場力学

  • ポイントオブケア診断市場に影響を与える要因
  • 市場促進要因
  • 感染症の発生率の高さ
  • 慢性疾患の増加
  • 自己検査の需要増加
  • 高齢化社会
  • 市場抑制要因
  • 価格圧力によりPOCメーカーが直面する課題
  • 技術的な複雑さ
  • 専門的な訓練の欠如
  • 市場の課題
  • 遠隔地でのポイントオブケア診断の導入における課題
  • ポイントオブケア診断における環境と汚染の課題
  • 市場機会
  • R&D予算の増加
  • AIとMLの統合によるPOCTの優れた市場可能性
  • 新興経済国

第4章 市場セグメンテーション分析

  • セグメンテーションの内訳
  • ポイントオブケア診断市場:検査タイプ別
  • 薬物およびアルコール検査
  • 血液ガス電解質および代謝物 (BGEM)
  • 心臓マーカー
  • コレステロール検査/モニタリング
  • 血糖値検査・モニタリング
  • 感染症検査
  • 妊娠・生殖能力検査
  • ヘモグロビン・止血
  • 腫瘍マーカー
  • 尿検査/尿化学
  • その他
  • ポイントオブケア診断市場:製品別
  • ハードウェア
  • ソフトウェア
  • ポイントオブケア診断市場:エンドユーザー別
  • 病院・集中治療室
  • ホームケア設定
  • 地理的内訳
  • ポイントオブケア診断市場:地域別
  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第5章 市場における新興技術と今後の技術

  • 新興技術と今後の技術
  • ポイントオブケア診断におけるAI
  • CRISPR-Casシステム
  • 3Dラピッドプロトタイピング
  • 量子ドット
  • RFIDとNFC
  • スマートフォンベースの医療画像
  • 病原体検出用POCデバイスにおけるナノマテリアル
  • マイクロ流体ベースのセンシング技術
  • クラウド統合AI
  • D3アレイ-UTI
  • EVIK DxSpheres:堅牢なアッセイソリューション
  • UNIQO 160自動IIFTシステム

第6章 ESGの展開

  • プラスチックとバイオベースの代替品の持続可能性
  • ESGリスク評価
  • WHO Global Action Plan
  • BCCによる見解

第7章 競合情勢

  • M&A・提携
  • 戦略的提携
  • FDA承認
  • 特許分析
  • 特許分析:年別
  • 企業シェア分析

第8章 付録

  • 調査手法
  • 出典
  • 略語
  • 企業プロファイル
  • ABBOTT
  • BD
  • DANAHER CORP.
  • GE HEALTHCARE
  • F. HOFFMANN-LA ROCHE LTD.
  • MEDTRONIC
  • QUEST DIAGNOSTICS INC.
  • QUIDELORTHO CORP.
  • SIEMENS HEALTHINEERS AG
  • THERMO FISHER SCIENTIFIC INC.
図表

List of Tables

  • Summary Table : Global Market for Point-of-Care Diagnostics, by Region, Through 2029
  • Table 1 : POCT Alternatative Terms
  • Table 2 : Commonly Used POC Devices
  • Table 3 : Recent Tests Approved by the FDA as Waived Tests Under CLIA
  • Table 4 : Estimated Number of People Living with HIV, 2010, 2021 and 2022
  • Table 5 : Number of Hepatitis B Infections (All Ages) in 2022
  • Table 6 : Global Incidences of STIs, 2020 and 2022
  • Table 7 : Projected Number of Adults 50 Years and Older with >=1 Chronic Condition in the United States, 2020-2050
  • Table 8 : Number and Proportion of Persons Aged 65 Years and Over, by Development Group, 2023 and 2050
  • Table 9 : Number of Persons Aged 65 Years and Over, by Region, 2019 and 2050
  • Table 10 : Number of Deaths and the Age-Adjusted Death Rate for the 10 Leading Causes of Death in 2022: United States, 2021 and 2022
  • Table 11 : Global Market for Point-of-Care Diagnostics, by Test Type, Through 2029
  • Table 12 : Global Market for Drug and Alcohol Screening, by Region, Through 2029
  • Table 13 : Global Market for BGEM, by Region, Through 2029
  • Table 14 : Global Market for Cardiac Markers, by Region, Through 2029
  • Table 15 : Global Market for Cholesterol Testing/Monitoring, by Region, Through 2029
  • Table 16 : Global Market for Glucose Testing and Monitoring, by Region, Through 2029
  • Table 17 : Annual Estimated Deaths from HIV/AIDS, Diarrhea, Malaria, Respiratory Infections, and All Other Infectious Diseases in Major Countries, 1980 to 2021
  • Table 18 : Global Market for Infectious Disease Testing, by Region, Through 2029
  • Table 19 : Global Market for Pregnancy and Fertility Testing, by Region, Through 2029
  • Table 20 : Global Market for Hemoglobin and Hemostasis, by Region, Through 2029
  • Table 21 : Examples of Commercially Available POC Devices for Cancer Detection
  • Table 22 : Global Market for Tumor Markers, by Region, Through 2029
  • Table 23 : Some Currently Available Point-of-Care Tests for Proteins in Urine
  • Table 24 : Global Market for Urinalysis/Urine Chemistry, by Region, Through 2029
  • Table 25 : Global Market for Other Types of Point-of-Care Diagnostics Tests, by Region, Through 2029
  • Table 26 : Global Market for Point-of-Care Diagnostics, by Product, Through 2029
  • Table 27 : Global Market for Hardware in Point-of-Care Diagnostics, by Region, Through 2029
  • Table 28 : Global Market for Software in Point-of-Care Diagnostics, by Region, Through 2029
  • Table 29 : Global Market for Point-of-Care Diagnostics, by End User, Through 2029
  • Table 30 : Global Market for Point-of-Care Diagnostics in Hospital and Critical Care End Uses, by Region, Through 2029
  • Table 31 : Global Market for Point-of-Care Diagnostics in Home Care Settings, by Region, Through 2029
  • Table 32 : Global Market for Point-of-Care Diagnostics, by Region, Through 2029
  • Table 33 : North American Market for Point-of-Care Diagnostics, by Test Type, Through 2029
  • Table 34 : North American Market for Point-of-Care Diagnostics, by Product, Through 2029
  • Table 35 : North American Market for Point-of-Care Diagnostics, by End User, Through 2029
  • Table 36 : North American Market for Point-of-Care Diagnostics, by Country, Through 2029
  • Table 37 : U.S. Market for Point-of-Care Diagnostics, by Test Type, Through 2029
  • Table 38 : U.S. Market for Point-of-Care Diagnostics, by Product, Through 2029
  • Table 39 : U.S. Market for Point-of-Care Diagnostics, by End User, Through 2029
  • Table 40 : Canadian Market for Point-of-Care Diagnostics, by Test Type, Through 2029
  • Table 41 : Canadian Market for Point-of-Care Diagnostics, by Product, Through 2029
  • Table 42 : Canadian Market for Point-of-Care Diagnostics, by End User, Through 2029
  • Table 43 : Mexican Market for Point-of-Care Diagnostics, by Test Type, Through 2029
  • Table 44 : Mexican Market for Point-of-Care Diagnostics, by Product, Through 2029
  • Table 45 : Mexican Market for Point-of-Care Diagnostics, by End User, Through 2029
  • Table 46 : European Market for Point-of-Care Diagnostics, by Test Type, Through 2029
  • Table 47 : European Market for Point-of-Care Diagnostics, by Product, Through 2029
  • Table 48 : European Market for Point-of-Care Diagnostics, by End User, Through 2029
  • Table 49 : European Market for Point-of-Care Diagnostics, by Country, Through 2029
  • Table 50 : Leading Causes of Disease Burden by DALYs (Level 3)
  • Table 51 : German Market for Point-of-Care Diagnostics, by Test Type, Through 2029
  • Table 52 : German Market for Point-of-Care Diagnostics, by Product, Through 2029
  • Table 53 : German Market for Point-of-Care Diagnostics, by End User, Through 2029
  • Table 54 : U.K. Market for Point-of-Care Diagnostics, by Test Type, Through 2029
  • Table 55 : U.K. Market for Point-of-Care Diagnostics, by Product, Through 2029
  • Table 56 : U.K. Market for Point-of-Care Diagnostics, by End User, Through 2029
  • Table 57 : French Market for Point-of-Care Diagnostics, by Test Type, Through 2029
  • Table 58 : French Market for Point-of-Care Diagnostics, by Product, Through 2029
  • Table 59 : French Market for Point-of-Care Diagnostics, by End User, Through 2029
  • Table 60 : Italian Market for Point-of-Care Diagnostics, by Test Type, Through 2029
  • Table 61 : Italian Market for Point-of-Care Diagnostics, by Product, Through 2029
  • Table 62 : Italian Market for Point-of-Care Diagnostics, by End User, Through 2029
  • Table 63 : Spanish Market for Point-of-Care Diagnostics, by Test Type, Through 2029
  • Table 64 : Spanish Market for Point-of-Care Diagnostics, by Product, Through 2029
  • Table 65 : Spanish Market for Point-of-Care Diagnostics, by End User, Through 2029
  • Table 66 : Rest of European Market for Point-of-Care Diagnostics, by Test Type, Through 2029
  • Table 67 : Rest of European Market for Point-of-Care Diagnostics, by Product, Through 2029
  • Table 68 : Rest of European Market for Point-of-Care Diagnostics, by End User, Through 2029
  • Table 69 : Asia-Pacific Market for Point-of-Care Diagnostics, by Test Type, Through 2029
  • Table 70 : Asia-Pacific Market for Point-of-Care Diagnostics, by Product, Through 2029
  • Table 71 : Asia-Pacific Market for Point-of-Care Diagnostics, by End User Through 2029
  • Table 72 : Asia-Pacific Market for Point-of-Care Diagnostics, by Country, Through 2029
  • Table 73 : Chinese Market for Point-of-Care Diagnostics, by Test Type, Through 2029
  • Table 74 : Chinese Market for Point-of-Care Diagnostics, by Product, Through 2029
  • Table 75 : Chinese Market for Point-of-Care Diagnostics, by End User, Through 2029
  • Table 76 : Japanese Market for Point-of-Care Diagnostics, by Test Type, Through 2029
  • Table 77 : Japanese Market for Point-of-Care Diagnostics, by Product, Through 2029
  • Table 78 : Japanese Market for Point-of-Care Diagnostics, by End User, Through 2029
  • Table 79 : Indian Market for Point-of-Care Diagnostics, by Test Type, Through 2029
  • Table 80 : Indian Market for Point-of-Care Diagnostics, by Product, Through 2029
  • Table 81 : Indian Market for Point-of-Care Diagnostics, by End User, Through 2029
  • Table 82 : Australian Market for Point-of-Care Diagnostics, by Test Type, Through 2029
  • Table 83 : Australian Market for Point-of-Care Diagnostics, by Product, Through 2029
  • Table 84 : Australian Market for Point-of-Care Diagnostics, by End User, Through 2029
  • Table 85 : South Korean Market for Point-of-Care Diagnostics, by Test Type, Through 2029
  • Table 86 : South Korean Market for Point-of-Care Diagnostics, by Product, Through 2029
  • Table 87 : South Korean Market for Point-of-Care Diagnostics, by End User, Through 2029
  • Table 88 : Rest of Asia-Pacific Market for Point-of-Care Diagnostics, by Test Type, Through 2029
  • Table 89 : Rest of Asia-Pacific Market for Point-of-Care Diagnostics, by Product, Through 2029
  • Table 90 : Rest of Asia-Pacific Market for Point-of-Care Diagnostics, by End User, Through 2029
  • Table 91 : Rest of the World Market for Point-of-Care Diagnostics, by Test Type, Through 2029
  • Table 92 : Rest of the World Market for Point-of-Care Diagnostics, by Product, Through 2029
  • Table 93 : Rest of the World Market for Point-of-Care Diagnostics, by End User, Through 2029
  • Table 94 : Growing Burden of Waste from Diagnostic Devices
  • Table 95 : Emerging and Sustainable Materials for the Fabrication of Single-Use POCT
  • Table 96 : ESG Highlights, by Major Players, 2023
  • Table 97 : ESG Rankings for Point-of-Care Diagnostics Manufacturing Companies, 2023
  • Table 98 : Mergers and Acquisitions: Point-of-Care Diagnostics Market, by Manufacturers, 2021-2024
  • Table 99 : Major Strategic Alliances in the Point-of-Care Diagnostic Industry, 2021-2024
  • Table 100 : FDA Approved Point-of-Care Diagnostics Devices, 2022-2023
  • Table 101 : Patents on on Point-of-Care Diagnostics, by Year, 2021-August 2024
  • Table 102 : Information Sources in this Report
  • Table 103 : Major Abbreviations Used in This Report
  • Table 104 : Abbott: Company Snapshot
  • Table 105 : Abbott: Financial Performance, FY 2022 and 2023
  • Table 106 : Abbott: Product Portfolio
  • Table 107 : Abbott: News/Key Developments, 2021-2024
  • Table 108 : BD: Company Snapshot
  • Table 109 : BD: Financial Performance, FY 2022 and 2023
  • Table 110 : BD: Product Portfolio
  • Table 111 : BD: News/Key Developments, 2022-2023
  • Table 112 : Danaher Corp.: Company Snapshot
  • Table 113 : Danaher Corp.: Financial Performance, FY 2022 and 2023
  • Table 114 : Danaher Corp.: Product Portfolio
  • Table 115 : Danaher Corp.: News/Key Developments, 2023 and 2024
  • Table 116 : GE Healthcare: Company Snapshot
  • Table 117 : GE Healthcare: Financial Performance, FY 2022 and 2023
  • Table 118 : GE Healthcare: Product Portfolio
  • Table 119 : GE Healthcare: News/Key Developments, 2023 and 2024
  • Table 120 : F. Hoffmann-La Roche Ltd.: Company Snapshot
  • Table 121 : F. Hoffmann-La Roche Ltd.: Financial Performance, FY 2022 and 2023
  • Table 122 : F. Hoffmann-La Roche Ltd.: Product Portfolio
  • Table 123 : F. Hoffmann-La Roche Ltd.: News/Key Developments, 2021-2024
  • Table 124 : Medtronic: Company Snapshot
  • Table 125 : Medtronic: Financial Performance, FY 2022 and 2023
  • Table 126 : Medtronic: Product Portfolio
  • Table 127 : Medtronic: News/Key Developments, 2023
  • Table 128 : Quest Diagnostics Inc.: Company Snapshot
  • Table 129 : Quest Diagnostics Inc.: Financial Performance, FY 2022 and 2023
  • Table 130 : Quest Diagnostics Inc.: Product Portfolio
  • Table 131 : Quest Diagnostics Inc.: News/Key Developments, 2021-2024
  • Table 132 : QuidelOrtho Corp.: Company Snapshot
  • Table 133 : QuidelOrtho Corp.: Financial Performance, FY 2022 and 2023
  • Table 134 : QuidelOrtho Corp.: Product Portfolio
  • Table 135 : QuidelOrtho Corp.: News/Key Developments, 2022-2024
  • Table 136 : Siemens Healthineers AG: Company Snapshot
  • Table 137 : Siemens Healthineers AG: Financial Performance, FY 2022 and 2023
  • Table 138 : Siemens Healthineers AG: Product Portfolio
  • Table 139 : Siemens Healthineers AG: News/Key Developments, 2023 and 2024
  • Table 140 : Thermo Fisher Scientific Inc.: Company Snapshot
  • Table 141 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
  • Table 142 : Thermo Fisher Scientific Inc.: Product Portfolio
  • Table 143 : Thermo Fisher Scientific Inc.: News/Key Developments, 2021-2024

List of Figures

  • Summary Figure : Global Market for Point-of-Care Diagnostics, by Region, 2021-2029
  • Figure 1 : Global Market Dynamics of Point-of-Care Diagnostics
  • Figure 2 : Malaria-Endemic Countries, 2022
  • Figure 3 : Top 10 Common Chronic Conditions in Adults 65+, U.S., 2024
  • Figure 4 : Annual Investment in STI Research Needs of People in Low- and Middle-Income Countries, 2018-2022
  • Figure 5 : Global Market Shares of Point-of-Care Diagnostics, by Test Type, 2023
  • Figure 6 : Share of New Cancer Cases Globally, by Region, 2022
  • Figure 7 : Share of Cancer Mortality Cases Globally, by Region, 2022
  • Figure 8 : Global Market Shares of Point-of-Care Diagnostics, by Product, 2023
  • Figure 9 : Global Market Shares of Point-of-Care Diagnostics, by End User, 2023
  • Figure 10 : COVID-19 Diagnostic Possibilities, Sampling, and Turnaround Time
  • Figure 11 : Global Market Shares of Point-of-Care Diagnostics, by Region, 2023
  • Figure 12 : North American Market Shares in Point-of-Care Diagnostics, by Country, 2023
  • Figure 13 : Limitations of Using POC Devices in India
  • Figure 14 : Overview of the POCT Life Cycle Associated with Environmental Burdens and Sustainable Solutions for Each Stage
  • Figure 15 : Share of Patents Published on Point-of-Care Diagnostics, by Country, 2021-2024
  • Figure 16 : Global Market Shares of Point-of-Care Diagnostics, by Manufacturer/Supplier, 2023
  • Figure 17 : Abbott: Revenue Share, by Country/Region, FY 2023
  • Figure 18 : Abbott: Revenue Share, by Business Unit, FY 2023
  • Figure 19 : BD: Revenue Share, by Country/Region, FY 2023
  • Figure 20 : BD: Revenue Share, by Business Unit, FY 2023
  • Figure 21 : Danaher Corp.: Revenue Share, by Business Unit, FY 2023
  • Figure 22 : Danaher Corp.: Revenue Share, by Country/Region, FY 2023
  • Figure 23 : GE Healthcare: Revenue Share, by Business Unit, FY 2023
  • Figure 24 : GE Healthcare: Revenue Share, by Country/Region, FY 2023
  • Figure 25 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Business Unit, FY 2023
  • Figure 26 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Country/Region, FY 2023
  • Figure 27 : Medtronic: Revenue Share, by Country/Region, FY 2023
  • Figure 28 : Medtronic: Revenue Share, by Business Unit, FY 2023
  • Figure 29 : Quest Diagnostics Inc.: Revenue Share, by Business Unit, FY 2023
  • Figure 30 : QuidelOrtho Corp.: Revenue Share, by Business Unit, FY 2023
  • Figure 31 : QuidelOrtho Corp.: Revenue Share, by Country/Region, FY 2023
  • Figure 32 : Siemens Healthineers AG: Revenue Share, by Business Unit, FY 2023
  • Figure 33 : Siemens Healthineers AG: Revenue Share, by Country/Region, FY 2023
  • Figure 34 : Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, FY 2023
  • Figure 35 : Thermo Fisher Scientific Inc.: Revenue Share, by Region, FY 2023
目次
Product Code: HLC043H

The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.

The North American market for point-of-care diagnostics is expected to grow from $16.8 billion in 2024 to $27.7 billion by the end of 2029, at a CAGR of 10.5% from 2024 through 2029.

The Asia-Pacific market for point-of-care diagnostics is expected to grow from $9.1 billion in 2024 to $15.4 billion by the end of 2029, at a CAGR of 11.2% from 2024 through 2029.

Report Scope

The point-of-care diagnostics market is extensive and constantly evolving with new technologies and methodologies. This report explores the current and future market potential, competitive environment, regulatory scenario, and market trends, including projections through 2029 and an analysis of key players.

This report covers the entire industry, including hardware (devices, equipment, consumables), software, and analytics. The market is analyzed by test type, including alcohol and drug abuse, blood gas electrolyte and metabolite (BGEM), cardiac markers, cholesterol, glucose monitoring, hemoglobin/hemostasis, infectious disease, pregnancy and fertility, tumor markers, and urine chemistry, and it includes comprehensive regional analyses.

The report highlights ongoing R&D efforts focused on improving accuracy accessibility and incorporating innovative diagnostic procedures. It provides insights into market drivers, challenges, opportunities, industry status, developments, trends, and strategies like mergers, acquisitions, and collaborations. It is a valuable resource for market players, potential entrants, government agencies, and other stakeholders, especially those interested in geographic expansion.

Report Includes

  • 98 data tables and 46 additional tables
  • An overview of the global markets and technologies for point-of-care (POC) diagnostics
  • Analyses of global market trends, with market revenue data (sales figures) for 2021-2023, estimates for 2024, and projected CAGRs through 2029
  • Estimates of the market size and revenue forecasts for the PoC diagnostics market, with market share analysis by test type, product type, end user, and region
  • Discussions of the market dynamics, opportunities and challenges, as well as emerging technologies
  • Coverage of government regulations and policies, R&D initiatives, exploration activities, and government programs
  • Overview of the sustainability trends and ESG developments in the industry, with emphasis on the ESG practices of leading companies, their ESG scores, and consumer attitudes
  • Competitive intelligence, including companies' market shares, recent M&A activity and venture funding
  • Profiles of the leading companies, including Abbott, BD, Danaher Corp., Thermo Fisher Scientific Inc., and F. Hoffmann-La Roche Ltd.

Table of Contents

Chapter 1 Executive Summary

  • Market Outlook
  • Scope of Report
  • Market Summary

Chapter 2 Market Overview

  • Overview
  • Novel Approaches for POC
  • Significance of CLIA in the United States
  • Regulatory Guidelines
  • Good Manufacturing Practice
  • The FDA's Role in POC Testing
  • Conclusion

Chapter 3 Market Dynamics

  • Factors Affecting the Point-of-Care Diagnostic Market
  • Market Drivers
  • High Incidences of Infectious Diseases
  • Growing Prevalence of Chronic Diseases
  • Increasing Demand for Self-Testing
  • Aging Population
  • Market Restraints
  • Challenges Faced by POC Manufacturers Due to Pricing Pressure
  • Technical Complexity
  • Lack of Specialized Training
  • Market Challenges
  • Challenges in Deploying Point-of-Care (POC) Diagnostics in Remote Settings
  • Environmental and Contamination Challenges in Point-of-Care Diagnostics
  • Market Opportunities
  • Increasing R&D Budget
  • Excellent Market Potential for POCT with AI and ML Integration
  • Emerging Economies

Chapter 4 Market Segmentation Analysis

  • Segmentation Breakdown
  • Point-of-Care Diagnostics Market, by Test Type
  • Drug and Alcohol Screening
  • Blood Gas Electrolyte and Metabolite (BGEM)
  • Cardiac Markers
  • Cholesterol Testing/Monitoring
  • Glucose Testing and Monitoring
  • Infectious Disease Testing
  • Pregnancy and Fertility Testing
  • Hemoglobin and Hemostasis
  • Tumor Marker
  • Urinalysis/Urine Chemistry
  • Others
  • Point-of-Care Diagnostics Market, by Product
  • Hardware
  • Software
  • Point-of-Care Diagnostics Market, by End User
  • Hospitals and Critical Care Settings
  • Home Care Settings
  • Geographic Breakdown
  • Point-of-Care Diagnostics Market, by Region
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)

Chapter 5 Emerging and Upcoming Technologies in the Market

  • Emerging and Upcoming Technologies
  • AI in Point-of-Care Diagnostics
  • CRISPR-Cas Systems
  • 3D Rapid Prototyping
  • Quantum Dots
  • RFID (Radio-Frequency Identification) and NFC (Near Field Communication)
  • Smartphone-Based Medical Imaging
  • Nanomaterials in POC Devices for Pathogen Detection
  • Microfluidics-Based Sensing Technologies
  • Cloud-Integrated AI
  • D3 Array-UTI
  • EVIK DxSpheres: A Solid Assay Solution
  • UNIQO 160 Automated IIFT System
    • Recent Developments

Chapter 6 ESG Development

  • Introduction
  • Sustainability in Plastics and Bio-Based Alternatives
  • ESG Risk Ratings
  • The WHO Global Action Plan
  • BCC Research Viewpoint

Chapter 7 Competitive Landscape

  • Mergers, Acquisitions and Collaborations
  • Strategic Alliances
  • FDA Approvals
  • Patent Analysis
  • Patent Analysis, by Year
  • Company Share Analysis

Chapter 8 Appendix

  • Methodology
  • Sources
  • Abbreviations
  • Company Profiles
  • ABBOTT
  • BD
  • DANAHER CORP.
  • GE HEALTHCARE
  • F. HOFFMANN-LA ROCHE LTD.
  • MEDTRONIC
  • QUEST DIAGNOSTICS INC.
  • QUIDELORTHO CORP.
  • SIEMENS HEALTHINEERS AG
  • THERMO FISHER SCIENTIFIC INC.